Prime Minister Putin was also characteristically direct and painted a robust view of the role that Russia plans to play in the medium-term governance of the global economy, building on their resource strength and technology innovation.
In a June article in The New England Journal of Medicine, Jerry Avorn, a pharmacologist at Harvard Medical School, painted torcetrapib as the unhappy result of the drug industry's role as the sole funder of most pricey pharmaceutical research.